Company intelligence / Profile preview

Invivo Biosciences

Lawrenceville, Georgia, USAinvivobiosciences.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Invivo Biosciences is a global provider of microbial fermentation solutions for agriculture, aquaculture, wastewater treatment and poultry industries. It also operates as a contract research organization offering discovery/development services using small laboratory animals for pharmaceutical R&D. The company specializes in probiotic strains such as Bacillus coagulans and B. subtilis with applications ranging from gut health to pathogen control. No proprietary drug clinical results reported.

Therapeutic areas: Metabolic DisordersOncologyImmunologyGastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: Microbial therapyProbioticSmall moleculePolyclonal antibody
Industry: Non-Drug Biotech

Partnerships

None publicized

Beyond the preview

Go deeper on Invivo Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invivo Biosciences.

Explore the full profile